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a  b  s  t  r  a  c  t
Behc¸et’s disease is a multisystemic disease consisting of a varying combination of ocular,
mucocutaneous, neurologic, cardiovascular, gastrointestinal and other manifestations. Its
diagnosis is based on clinical criteria, in which a positive pathergy test scores 1. A case series
with 26 suspected patients is presented, and the skin pathergy test was performed in 23.
The  results were read in 48 hours, and they were considered negative when without papule,
and  positive with a papule or pustule. Positive results were divided by papule size, and
dermatoscopy was done to measure and observe its clinical aspects. After the readings, a
biopsy was performed, with annotation of histopathological aspects. The test was negative
in  2 (8.7%) and positive in 21 (91.3%) patients. The results and the literature review are
presented.
©  2014 Elsevier Editora Ltda. All rights reserved.
Dermatoscopia  no  teste  cutâneo  da  patergia:  série  de  casos  de  pacientes
com  suspeita  de  Doenc¸a de  Behc¸et
Palavras-chave:
Doenc¸a de Behc¸et
Técnicas e procedimentos
diagnósticos
r  e  s  u  m  o
A doenc¸a de Behc¸et é uma doenc¸a multissistêmica que consiste de diferentes combinac¸ões
de  manifestac¸ões oculares, mucocutâneas, neurológicas, cardiovasculares, gastrintesti-
nais  e outras. Seu diagnóstico se fundamenta em critérios clínicos, em que o teste da
patergia positivo recebe um ponto. Apresenta-se uma série de casos com 26 pacientes
Vasculite suspeitos, tendo o teste da patergia da pele sido realizado em 23 deles. Os resultados
foram avaliados em 48 horas, tendo sido considerados como negativos diante da ausên-
cia  de pápula e positivos na presenc¸a de pápula ou pústula. Os resultados positivos foram
divididos pelo tamanho da pápula, efetuou-se uma dermatoscopia para medir e obser-
var  seus aspectos clínicos. Após as leituras, foi realizada uma  biópsia, com anotac¸ão dos
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aspectos histopatológicos. O teste foi negativo em 2 (8,7%) e positivo em 21 (91,3%) pacientes.
Apresentam-se os resultados e a revisão da literatura.
© 2014 Elsevier Editora Ltda. Todos os direitos reservados.
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ehc¸et’s disease (BD) is classiﬁed among vasculitides.1 It was
rst deﬁned as a triad of recurrent aphtous stomatitis, geni-
al aphtae and relapsing uveitis in 1937 by Hulusi Behc¸et. It
s considered a multisystemic disease consisting of varying
ombination of ocular, mucocutaneous, neurologic, cardiovas-
ular, gastrointestinal and other manifestations.2–7
Its diagnosis is based on clinical criteria. The New Interna-
ional Criteria for Behc¸et’s Disease are one of the most recently
evised diagnostic criteria. A diagnosis of BD consists of a sum
f three or more  points according to a score system. Positive
athergy test scores 1 point (Table 1).8
Pathergy is a hyper reactivity of the skin after a needle
rauma. It was ﬁrst described in 1937 and it is consid-
red pathognomonic, although it can be seen in pyoderma
angrenosum, erythema elevatum diutinum and other neu-
rophilic dermatoses, including Sweet syndrome and the blind
oop syndrome.9 It is reported that about 8% of inﬂammatory
owel disease patients show this phenomenon.10
In spite of its high speciﬁcity, the skin pathergy response
as variable sensitivity and inconstant reproducibility, which
imit its use. Regardless of this, it is used in many  sets of clas-
iﬁcation/diagnosis criteria.1,9,11,12
ethods
 case series study was done with twenty-six suspected BD
atients (23 women and three men) referred to a private clinic
o be tested for pathergy phenomenon.Out of 26 patients, the pathergy test was performed in 23
atients, as three of them (two men  and one woman), which
lready fulﬁlled the diagnosis of BD did not agree to be tested.
ight patients did not present disease activity (presence of
Table 1 – Revised international criteria for Behc¸et’s
disease.
Criterion Score
(point)
Oral aphtosis 1
Skin manifestations (erythema
nodosum-like lesions, papulopustular
lesions or pseudofoliculitis, acneiform
nodules)
1
Vascular lesions (arterial and venous
thrombosis, aneurysm)
1
Pathergy phenomenon (test) 1
Genital aphtosis 2
Ocular lesions 2
Behc¸et’s Disease, three or more points.symptoms or signs) during the test, contrasting to 15 who
did. Five patients were in treatment (taking less than 20 mg
of prednisone) when it was performed.
Six needle pricks using 21 gauge disposable needles were
done intradermally at the same point on the skin of the fore-
arm, after cleaning the site with 70% ethanol swabs. Results
were read by the same observer 48 hours later.
They were considered negative if without papule and only
needle mark or erythema and positive if with papule or pus-
tule surrounded by an erythema. Dermatoscopy was done to
measure the reaction and observe its clinical aspects.
After the readings a biopsy was performed and stained
with hematoxylin and eosin (HE). In some cases more  than 1
point of multiple punctures were performed (two prick tests)
to choose the biggest papule to biopsy.
Results
Among the patients, 23 were women and 3 men. The age
ranged from 11 to 72 years and the average age was 33.11,
with standard deviation 14.73.
The oral lesions were present in all patients (100%), fol-
lowed by genital lesions, observed in 12 (46.1%), ocular lesions
in 10 (38,5%), skin lesions in 10 (38.5%), and joint and neuro-
logical involvement in 13 (50%) and two (7.7%), respectively
(Table 2).
The pathergy test was negative in two BD patients (8.7%)
and positive in 21 (91.3%). Among the positive tests, four
(17.4%) were less than 1 mm,  16 (69.5%) were between 1-2 mm
and one (4.3%) more  than 2 mm.  These results were not cor-
related with the disease activity or treatment. Dermatoscopy
showed needle marks and mild erythema in the negative tests
(2 patients) and erythematous papule/pustule or exulcerocros-
tous lesions surrounded by erythematous and/or edematous
area in the positives (21 patients) (Table 3). It was a good tool
especially to measure and examine the inﬂammatory aspects
of the small lesions (less than 2 mm).  Figure 1 shows the der-
matoscopic aspect of a pathergy test.
The main histopathologic ﬁndings of the 23 biopsed
patients were: perivascular inﬂammatory inﬁltration in 19
Table 2 – Clinical manifestations in 26 patients with
suspected BD.
Clinical manifestation Absolute
number (%)
oral 26 (100)
genital 12 (46)
ocular 10 (38)
cutaneous 12 (46)
arthritis 13 (50)
neurological 2 (7,6)
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s. Figure 1 – The dermatoscopic aspect of a pathergy test.
(82.6%), deposition of ﬁbrinoid material in 16 (69.5%), extrava-
sation of erytrocytes in 13 (56.5%), intersticial inﬂammatory
inﬁltration in 10 (43.5%). Other detected alterations were:
presence of neutrophils or eosinophils, micorabscesses, leu-
cocytoclasis, edema, necrosis, nuclear debris, vasculitis and
damage of vessel walls (Table 3).
After testing, the ﬁnal diagnosis was: 20 patients (77%)
fulﬁlled the International Study Group (ISG) criteria for the
diagnosis of BD (Table 1), and 6 (23%), who did not, were clas-
siﬁed as having suspected BD.
Discussion
Positive pathergy is amongst the criteria for a diagnosis of BD.
Therefore, the study of this phenomenon is important not only
to make the diagnosis but also to understand the disease.
Although its aetiology is still unknown, endothelial dys-
function is a prominent feature in BD. Thrombomodulin
(TM) is a membrane-bound receptor of thrombin on vascu-
lar endothelial cells, which activates protein C and inactivates
thrombin. It is downregulated by inﬂammatory cytoquines,
leading to a procoagulant state of the endothelium. TM is also
expressed by spinous keratinocytes. High blood levels of TM
were strongly correlated with positive skin pathergy test (SPT),
suggesting that this test could be an alternative to the SPT.8,11
Positive SPT has been reported with high frequency from
most countries along the Silk Road but the sensitivity is
declining over the time.1,9 In a recent study, the sensitivity
of the pathergy phenomenon decreased gradually in Iranian
patients from 64.2% to 35.8%, and the reason remains obscure;
however, the speciﬁcity increased from 86.6% to 98.4%. There-
fore, the chances of getting a positive test have decreased, and
a positive test is rather synonymous with BD, with a proba-
bility of 98.4% (speciﬁcity).9 A recent study about the impact
of the positive SPT on the performance of the sets of classi-
ﬁcation/diagnosis criteria for BD showed that, without it, the
sensitivity of the majority of these sets decreases by 1.9 to 35%.
On the contrary, the speciﬁcity improves by 0.1-4.7%. Overall,
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he sets of criteria show a loss of accuracy, demonstrating that
his parameter is necessary to improve the power of existing
lassiﬁcation/diagnosis criteria.12
The mechanisms underlying pathergy are unknown. The
kin injury caused by the needle prick in the patient’s skin
pparently triggers a cutaneous inﬂammatory response which
s more  prominent and extensive than that seen in normal
kin. It is suggested that an increased and aberrant release of
ytokines from keratinocytes or other cells in the epidermis or
ermis results in a perivascular inﬁltration observed on skin
iopsy.8
Pathergy phenomenon was detected more  frequently in
LA-B51 patients especially in some countries.1,8
The forearm is the most frequently positive site and it is
ften chosen to perform the test.6,8,9,12
Studies have demonstrated that the use of a blunt,
e-usable, sterilized needle increases the frequency and inten-
ity of SPT. The introduction of disposable needles caused its
ecrease. Pathergy is further related to the diameter of the
eedle. A 20-gauge disposable needle gave a positive SPT in
2.5% but the result fell to 35.8% when 26-gauge needles were
sed. Other authors recommend the test with a 25 or 21-gauge
eedle inserted intradermally, perpendicular or diagonally to
he skin.1,6,8,9,12–14
Therefore, the intensity of the reaction was more  promi-
ent with thicker needles (20-gauge). The intracutaneous
hysiological injections, a method used by some investigators,
as the least sensitive.8
There is no consensus about the number of the needle
ricks required. Some studies used multiple pricks, which is
onsidered important to increase the positive rate of a SPT and
thers, one or two.1,3,8,9,13,14
Most investigators have read 24-48 h after the test, and
t is considered positive if an erythematous papule > 2 mm
n diameter or a pustule is observed. Others have reported
ositive results in the presence of a papule or pustule not
entioning its size. Therefore, the percentage of positive tests
iffers from one report to another not only because of ethnic
actors but also for this reason.1,3,5,6,8,9,13,14
In order to investigate the reactions, the SPT results were
ivided based on the size of the papule and a biopsy was taken
ven if the papule was smaller than 2 mm.
The higher frequency was found between 1-2 mm,  and the
ests bigger than 2 mm were detected in a low frequency (4.3%).
On the other hand, the histologic exams showed prominent
spects even when the sizes were smaller than 1 mm and for
hat reason all the results with the presence of a papule were
onsidered positive. In a study reported in Brazil, 91.6% of 24
atients had SPT negative, but the histopathology on the site
f the pathergy test showed inﬂammatory aspects in 83.3% of
hem.13
Although some authors do not recommend the biopsy of
he SPT, we  performed the histopathologic exam because,
ccording to our results, it conﬁrmed the inﬂammatory pro-
ess showing important ﬁndings to complement the test.8,13
The pathergy phenomenon is not constant during the
ourse of the disease. The degree of positivity may occa-
ionally correlate with disease activity.1,2,12 Reports do not
onﬁrm the relation between pathergy and clinic manifesta-
ions, being necessary longitudinal studies to establish it.2,12 4;5 4(6):494–498 497
There are apparent controversies about the histopatho-
logic ﬁndings of the SPT, since its methodology is variable and
evaluated after different time periods. In addition to this, a
study compared histopathologic and clinical evaluations and
concluded that histopathologic investigation was no more
sensitive than clinical observation, but in this series the test
was considered positive if > 2 mm.2,8,13
In our series a variety of histopathologic ﬁndings were
described but perivascular inﬁltration and deposition of ﬁb-
rinoid material were the most frequent, conﬁrming the
literature.
The expression pattern of adhesion molecules in pathergy
reaction suggested a direct epidermal injury as the cause of the
cutaneous inﬂammation. An intense antigen-independent
induction phase of cutaneous inﬂammation might be
developed by increasing the release of cytoquines from kera-
tinocytes, which might later be ampliﬁed by the effect of
inﬁltrating activated mononuclear cells.
In addition, the immunohistologic picture of the pathergy
reaction suggested a cell-mediated immune response.
Ethnic factors and the cross-sectional methodology of the
various studies performed in several countries may also inﬂu-
ence the reported histopathologic ﬁndings.2,8,13
Sometimes, the cutaneous inﬂammation due to the epi-
dermal injury caused by the pricking is so light that the
SPT is considered negative. However, when the reactions are
better observed by both dermatoscopy and histopathology,
and, consequently, even the tiny ones are considered pos-
itive, as described in our report, the frequency of positive
SPT increases. Therefore, this high frequency was detected
because of the methodology applied which valued the size and
histopathologic ﬁndings of the reactions.
Despite the controversies in the methodology of the SPT, it
is necessary to establish guidelines to perform it, since it is an
important key for the diagnosis of the BD.
Reports using dermatoscopy in the SPT were not found.
In conclusion, the dermatoscopy and histopathologic study
on the site of the punctures, performed 48 hours after the
pricking test, are strongly recommended for the investigation
of suspected BD patients, since they can reveal evidence of
inﬂammation even in the small lesions.
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